Cargando…
A narrative review of methods for the identification of ALK fusions in patients with non-small cell lung carcinoma
BACKGROUND AND OBJECTIVE: This narrative review is intended to provide pragmatic knowledge of current methods for the search of anaplastic lymphoma kinase (ALK) fusions in patients with non-small cell lung carcinoma (NSCLC). This information is very timely, because a recent survey has identified tha...
Autores principales: | Hernandez, Susana, Conde, Esther, Alonso, Marta, Illarramendi, Adrian, Bote de Cabo, Helena, Zugazagoitia, Jon, Paz-Ares, Luis, Lopez-Rios, Fernando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413037/ https://www.ncbi.nlm.nih.gov/pubmed/37577307 http://dx.doi.org/10.21037/tlcr-22-855 |
Ejemplares similares
-
Second-line Treatment of Non-Small Cell Lung Cancer: Focus on the Clinical Development of Dacomitinib
por: Zugazagoitia, Jon, et al.
Publicado: (2017) -
Rethinking the role of biomarkers for operable non-small cell lung carcinoma: an effective collaboration with artificial intelligence algorithms
por: Conde, Esther, et al.
Publicado: (2022) -
CMTR1-ALK: an ALK fusion in a patient with no response to ALK inhibitor crizotinib
por: Du, Xue, et al.
Publicado: (2018) -
Monomerization of ALK Fusion Proteins as a Therapeutic Strategy in ALK-Rearranged Non-small Cell Lung Cancers
por: Hirai, Noriko, et al.
Publicado: (2020) -
EML4-ALK fusion gene in non-small cell lung cancer
por: Lei, Yu, et al.
Publicado: (2022)